News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Nomura Expects JD HEALTH (06618.HK) 2HFY2025 Operating Profit to Rise 70%+, Keeps Buy Rating
Nomura anticipated JD HEALTH (06618.HK)'s 4FQ25 revenue to rise by 22% YoY to RMB20 billion, exceeding market expectations due to heightened demand for pharmaceuticals driven b...
Reset
Send
The window will close in 5 seconds
<Research>Nomura Expects JD HEALTH (06618.HK) 2HFY2025 Operating Profit to Rise 70%+, Keeps Buy Rating
Close
Recommend
4
Positive
7
Negative
2
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

Nomura anticipated JD HEALTH (06618.HK)  +0.320 (+0.658%)    Short selling $77.28M; Ratio 154.143%   's 4FQ25 revenue to rise by 22% YoY to RMB20 billion, exceeding market expectations due to heightened demand for pharmaceuticals driven by a surge in influenza cases during the period.

Combining a 1.6 ppts YoY increase in non-IFRS operating profit margin for 3FQ, the broker expected JD HEALTH's 2HFY2025 adjusted operating profit margin to improve by 1.3 ppts, and operating profit to grow by 72% YoY to RMB1.7 billion, with net profit potentially hiking by 27% YoY to RMB2.7 billion.

Therefore, Nomura raised its FY2025/ 2026 earnings forecasts for JD HEALTH by 1%, and kept rating at Buy and a target price of $80.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.